Universal Historical Cash Flow

601231 Stock   16.45  0.52  3.26%   
Analysis of Universal Scientific cash flow over time is an excellent tool to project Universal Scientific future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 1.2 B or Capital Expenditures of 1.7 B as it is a great indicator of Universal Scientific ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Universal Scientific latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Universal Scientific is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Universal Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Universal balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Universal's non-liquid assets can be easily converted into cash.

Universal Scientific Cash Flow Chart

At present, Universal Scientific's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Dividends Paid is expected to grow to about 1.2 B, whereas Change To Account Receivables is projected to grow to (2 B).

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Universal Scientific to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Universal Scientific operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Universal Scientific financial statement analysis. It represents the amount of money remaining after all of Universal Scientific Industrial operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Universal Scientific's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Universal Scientific current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Universal Scientific's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Dividends Paid is expected to grow to about 1.2 B, whereas Change To Account Receivables is projected to grow to (2 B).
 2021 2022 2023 2024 (projected)
Capital Expenditures1.5B1.7B1.6B1.7B
Dividends Paid1.2B644.4M1.1B1.2B

Universal Scientific cash flow statement Correlations

0.050.15-0.3-0.320.670.150.15-0.110.09-0.340.360.860.90.060.52-0.31
0.05-0.620.73-0.630.630.90.840.050.660.070.780.310.220.870.80.75
0.15-0.62-0.810.57-0.47-0.82-0.650.23-0.69-0.69-0.62-0.040.03-0.84-0.59-0.75
-0.30.73-0.81-0.60.480.760.780.080.550.410.730.07-0.040.740.480.73
-0.32-0.630.57-0.6-0.75-0.73-0.75-0.18-0.68-0.01-0.71-0.59-0.46-0.65-0.66-0.46
0.670.63-0.470.48-0.750.730.68-0.130.530.00.830.840.80.60.840.31
0.150.9-0.820.76-0.730.730.89-0.040.780.260.840.330.240.970.890.8
0.150.84-0.650.78-0.750.680.890.290.670.030.920.340.240.870.80.63
-0.110.050.230.08-0.18-0.13-0.040.29-0.24-0.430.08-0.08-0.160.0-0.080.06
0.090.66-0.690.55-0.680.530.780.67-0.240.130.560.160.080.720.70.51
-0.340.07-0.690.41-0.010.00.260.03-0.430.130.13-0.23-0.210.36-0.010.44
0.360.78-0.620.73-0.710.830.840.920.080.560.130.580.510.810.820.49
0.860.31-0.040.07-0.590.840.330.34-0.080.16-0.230.580.990.220.56-0.08
0.90.220.03-0.04-0.460.80.240.24-0.160.08-0.210.510.990.140.51-0.18
0.060.87-0.840.74-0.650.60.970.870.00.720.360.810.220.140.820.83
0.520.8-0.590.48-0.660.840.890.8-0.080.7-0.010.820.560.510.820.49
-0.310.75-0.750.73-0.460.310.80.630.060.510.440.49-0.08-0.180.830.49
Click cells to compare fundamentals

Universal Scientific Account Relationship Matchups

Universal Scientific cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory464.6M(1.4B)(2.2B)(1.9B)2.7B2.8B
Dividends Paid420.5M444.2M1.2B644.4M1.1B1.2B
Capital Expenditures673.6M1.1B1.5B1.7B1.6B1.7B
Total Cash From Operating Activities2.4B1.4B(1.1B)3.4B6.8B7.2B
Change To Account Receivables(1.8B)383.5M(2.6B)(2.3B)(2.1B)(2.0B)
Net Income1.3B1.7B1.9B3.1B1.9B1.2B
Total Cash From Financing Activities38.5M(384.3M)1.8B2.4B2.8B2.9B
Other Cashflows From Investing Activities84.3M92.0M77.7M98.1M88.3M99.3M
Investments465.8M(71.2M)(75.6M)(1.5B)(1.2B)(1.2B)
Change In Cash1.5B220.6M(285.0M)1.7B3.4B3.6B
Net Borrowings468.4M149.9M2.2B3.7B4.3B4.5B
Total Cashflows From Investing Activities(308.7M)(594.8M)(3.0B)(1.5B)(1.3B)(1.4B)
Depreciation515.7M596.3M884.9M994.2M1.1B720.9M
Change To Netincome159.7M(106.8M)(45.0M)136.0M156.4M164.2M
Change To Liabilities1.4B1.3B(165.2M)3.0B325.5M0.0
End Period Cash Flow6.1B6.3B6.0B7.7B9.8B6.9B
Free Cash Flow1.8B380.2M(2.6B)1.8B4.8B5.1B
Change In Working Capital605.7M(950.3M)(4.2B)(789.9M)3.1B3.2B
Begin Period Cash Flow4.6B6.1B6.3B6.0B6.4B6.2B
Other Non Cash Items151.3M114.8M358.5M233.5M564.9M593.1M

Currently Active Assets on Macroaxis

Other Information on Investing in Universal Stock

The Cash Flow Statement is a financial statement that shows how changes in Universal balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Universal's non-liquid assets can be easily converted into cash.